bionlp-st-ge-2016-spacy-parsed Home  

PMC:3342329 / 20097-21381 JSONTXT 24 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T11894 0-5 JJ denotes NF-κB
T11895 6-15 VBZ denotes regulates
T11896 16-19 DT denotes the
T11897 20-30 NN denotes expression
T11898 31-33 IN denotes of
T11899 34-38 IN denotes over
T11900 39-42 CD denotes 200
T11901 43-48 NNS denotes genes
T11902 49-53 WDT denotes that
T11903 54-61 VBP denotes control
T11904 62-65 DT denotes the
T11905 66-72 JJ denotes immune
T11906 73-79 NN denotes system
T11907 79-80 , denotes ,
T11908 81-87 NN denotes cancer
T11909 88-92 NN denotes cell
T11910 93-99 NN denotes growth
T11911 100-103 CC denotes and
T11912 104-116 NN denotes inflammation
T11913 117-118 NNP denotes [
T11914 118-120 CD denotes 39
T11915 120-121 NNP denotes ]
T11916 121-122 . denotes .
T11917 123-130 IN denotes Because
T11918 131-133 IN denotes of
T11919 134-137 PRP$ denotes its
T11920 138-147 NNS denotes abilities
T11921 148-150 TO denotes to
T11922 151-157 VB denotes induce
T11923 158-161 DT denotes the
T11924 162-172 NN denotes expression
T11925 173-175 IN denotes of
T11926 176-177 DT denotes a
T11927 178-183 JJ denotes large
T11928 184-189 NN denotes array
T11929 190-192 IN denotes of
T11930 193-205 JJ denotes inflammatory
T11931 206-215 NNS denotes mediators
T11932 216-219 CC denotes and
T11933 220-223 PRP$ denotes its
T11934 224-229 NNS denotes roles
T11935 230-232 IN denotes as
T11936 233-237 NN denotes core
T11937 238-251 NN denotes transcription
T11938 252-259 NNS denotes factors
T11939 260-262 IN denotes in
T11940 263-270 JJ denotes diverse
T11941 271-277 JJ denotes immune
T11942 278-287 NNS denotes responses
T11943 287-288 , denotes ,
T11944 289-294 NNP denotes NF-κB
T11945 295-298 VBZ denotes has
T11946 299-303 VBN denotes been
T11947 304-314 VBN denotes recognized
T11948 315-317 IN denotes as
T11949 318-319 DT denotes a
T11950 320-325 JJ denotes major
T11951 326-332 NN denotes factor
T11952 333-344 JJ denotes responsible
T11953 345-348 IN denotes for
T11954 349-368 JJ denotes cytokine-associated
T11955 369-375 NN denotes cancer
T11956 376-387 NN denotes development
T11957 388-390 CC denotes or
T11958 391-401 JJ denotes anti-tumor
T11959 402-410 NN denotes immunity
T11960 410-411 . denotes .
T11961 412-414 IN denotes In
T11962 415-418 DT denotes the
T11963 419-427 NN denotes melanoma
T11964 428-433 NN denotes tumor
T11965 434-441 NNS denotes tissues
T11966 442-444 IN denotes of
T11967 445-448 DT denotes the
T11968 449-453 NNP denotes CCR5
T11969 453-454 NNP denotes −
T11970 454-455 VBD denotes /
T11971 455-456 CD denotes −
T11972 457-461 NNS denotes mice
T11973 461-462 , denotes ,
T11974 463-466 DT denotes the
T11975 467-477 NN denotes expression
T11976 478-480 IN denotes of
T11977 481-486 JJ denotes NF-κB
T11978 487-493 NN denotes target
T11979 494-498 NN denotes cell
T11980 499-504 NN denotes death
T11981 505-510 NNS denotes genes
T11982 511-512 -LRB- denotes (
T11983 512-515 NNP denotes Bax
T11984 515-516 , denotes ,
T11985 517-526 JJ denotes caspase-3
T11986 527-530 CC denotes and
T11987 531-532 CD denotes 9
T11988 532-533 -RRB- denotes )
T11989 534-537 CC denotes and
T11990 538-541 DT denotes the
T11991 542-545 NNP denotes DNA
T11992 546-553 JJ denotes binding
T11993 554-562 NN denotes activity
T11994 563-565 IN denotes of
T11995 566-571 NNP denotes NF-κB
T11996 571-572 , denotes ,
T11997 573-577 VBD denotes were
T11998 578-591 RB denotes significantly
T11999 592-601 VBN denotes inhibited
T12000 601-602 , denotes ,
T12001 603-606 CC denotes but
T12002 607-610 DT denotes the
T12003 611-621 NN denotes expression
T12004 622-624 IN denotes of
T12005 625-629 NN denotes cell
T12006 630-635 NN denotes death
T12007 636-646 JJ denotes inhibitory
T12008 647-652 NN denotes NF-κB
T12009 653-659 NN denotes target
T12010 660-665 NNS denotes genes
T12011 665-666 , denotes ,
T12012 667-671 JJ denotes such
T12013 672-674 IN denotes as
T12014 675-680 NN denotes Bcl-2
T12015 681-684 CC denotes and
T12016 685-689 NNP denotes cIAP
T12017 690-694 VBD denotes were
T12018 695-703 VBN denotes enhanced
T12019 703-704 . denotes .
T12020 705-707 IN denotes In
T12021 708-716 NN denotes addition
T12022 716-717 , denotes ,
T12023 718-722 NNP denotes CCR5
T12024 722-723 VBD denotes −
T12025 723-724 CD denotes /
T12026 724-725 NN denotes −
T12027 726-735 VBD denotes prevented
T12028 736-739 DT denotes the
T12029 740-755 NN denotes phosphorylation
T12030 756-758 IN denotes of
T12031 759-762 NNP denotes IκB
T12032 762-763 , denotes ,
T12033 764-775 VBN denotes accompanied
T12034 776-780 IN denotes with
T12035 781-784 DT denotes the
T12036 785-795 NN denotes inhibition
T12037 796-798 IN denotes of
T12038 799-802 DT denotes the
T12039 803-806 CD denotes p50
T12040 807-810 CC denotes and
T12041 811-814 CD denotes p65
T12042 815-828 NN denotes translocation
T12043 829-833 IN denotes into
T12044 834-837 DT denotes the
T12045 838-845 NN denotes nucleus
T12046 846-847 -LRB- denotes (
T12047 847-853 NN denotes Figure
T12048 854-858 NN denotes 2A-C
T12049 858-859 -RRB- denotes )
T12050 859-860 . denotes .
T12051 861-865 JJ denotes Many
T12052 866-872 NNS denotes tumors
T12053 872-873 , denotes ,
T12054 874-883 VBG denotes including
T12055 884-892 NN denotes melanoma
T12056 892-893 , denotes ,
T12057 894-898 VBP denotes have
T12058 899-908 VBN denotes increased
T12059 909-915 NNS denotes levels
T12060 916-918 IN denotes of
T12061 919-924 NNP denotes NF-κB
T12062 925-926 NNP denotes [
T12063 926-928 CD denotes 40
T12064 928-929 NNP denotes ]
T12065 929-930 , denotes ,
T12066 931-936 WDT denotes which
T12067 937-939 VBZ denotes is
T12068 940-946 JJ denotes likely
T12069 947-953 VBG denotes acting
T12070 954-956 IN denotes as
T12071 957-958 DT denotes a
T12072 959-967 NN denotes survival
T12073 968-974 NN denotes factor
T12074 975-978 IN denotes for
T12075 979-987 NN denotes melanoma
T12076 988-994 NN denotes growth
T12077 994-995 . denotes .
T12078 996-1000 RB denotes Thus
T12079 1000-1001 , denotes ,
T12080 1002-1005 DT denotes the
T12081 1006-1017 NNS denotes inhibitions
T12082 1018-1020 IN denotes of
T12083 1021-1026 JJ denotes NF-κB
T12084 1027-1035 NN denotes activity
T12085 1036-1039 CC denotes and
T12086 1040-1043 DT denotes the
T12087 1044-1054 NN denotes expression
T12088 1055-1057 IN denotes of
T12089 1058-1064 NN denotes target
T12090 1065-1070 NNS denotes genes
T12091 1071-1074 VBP denotes are
T12092 1075-1083 JJ denotes critical
T12093 1084-1086 IN denotes in
T12094 1087-1090 DT denotes the
T12095 1091-1101 NN denotes inhibition
T12096 1102-1104 IN denotes of
T12097 1105-1110 NN denotes tumor
T12098 1111-1117 NN denotes growth
T12099 1118-1120 IN denotes in
T12100 1121-1125 CD denotes CCR5
T12101 1125-1126 CD denotes −
T12102 1126-1127 NN denotes /
T12103 1127-1128 NN denotes −
T12104 1129-1133 NNS denotes mice
T12105 1133-1134 . denotes .
T12106 1135-1143 IN denotes Although
T12107 1144-1147 DT denotes the
T12108 1148-1157 NN denotes mechanism
T12109 1158-1160 VBZ denotes is
T12110 1161-1164 RB denotes not
T12111 1165-1170 JJ denotes clear
T12112 1171-1173 IN denotes as
T12113 1174-1176 TO denotes to
T12114 1177-1180 WRB denotes how
T12115 1181-1185 NNP denotes CCR5
T12116 1185-1186 VBD denotes −
T12117 1186-1187 CD denotes /
T12118 1187-1188 NN denotes −
T12119 1189-1202 VBZ denotes downregulates
T12120 1203-1208 NNP denotes NF-κB
T12121 1208-1209 , denotes ,
T12122 1210-1212 PRP denotes it
T12123 1213-1215 VBZ denotes is
T12124 1216-1226 JJ denotes noteworthy
T12125 1227-1231 IN denotes that
T12126 1232-1237 NNP denotes NF-κB
T12127 1238-1240 VBZ denotes is
T12128 1241-1250 VBN denotes activated
T12129 1251-1253 CC denotes or
T12130 1254-1265 VBN denotes inactivated
T12131 1266-1268 IN denotes by
T12132 1269-1273 JJ denotes many
T12133 1274-1283 NNS denotes cytokines
T12134 1283-1284 . denotes .
R7773 T11921 T11922 aux to,induce
R7778 T11922 T11947 advcl induce,recognized
R7781 T11923 T11924 det the,expression
R7787 T11894 T11895 nsubj NF-κB,regulates
R7788 T11895 T11895 ROOT regulates,regulates
R7789 T11924 T11922 dobj expression,induce
R7790 T11896 T11897 det the,expression
R7791 T11897 T11895 dobj expression,regulates
R7792 T11898 T11897 prep of,expression
R7793 T11899 T11900 quantmod over,200
R7794 T11925 T11924 prep of,expression
R7795 T11900 T11901 nummod 200,genes
R7796 T11901 T11898 pobj genes,of
R7797 T11902 T11903 nsubj that,control
R7798 T11926 T11928 det a,array
R7799 T11903 T11901 relcl control,genes
R7800 T11904 T11906 det the,system
R7801 T11905 T11906 amod immune,system
R7802 T11927 T11928 amod large,array
R7803 T11906 T11903 dobj system,control
R7804 T11907 T11906 punct ",",system
R7805 T11908 T11909 compound cancer,cell
R7806 T11928 T11925 pobj array,of
R7807 T11909 T11910 compound cell,growth
R7808 T11910 T11906 conj growth,system
R7809 T11911 T11910 cc and,growth
R7810 T11929 T11928 prep of,array
R7811 T11912 T11910 conj inflammation,growth
R7812 T11913 T11915 nmod [,]
R7813 T11914 T11915 nummod 39,]
R7814 T11930 T11931 amod inflammatory,mediators
R7815 T11915 T11897 appos ],expression
R7816 T11916 T11895 punct .,regulates
R7817 T11931 T11929 pobj mediators,of
R7818 T11917 T11947 prep Because,recognized
R7819 T11918 T11917 pcomp of,Because
R7820 T11919 T11920 poss its,abilities
R7821 T11920 T11917 pobj abilities,Because
R7822 T11932 T11931 cc and,mediators
R7823 T11933 T11934 poss its,roles
R7824 T11934 T11931 conj roles,mediators
R7825 T11935 T11934 prep as,roles
R7826 T11936 T11938 amod core,factors
R7827 T12018 T11999 conj enhanced,inhibited
R7828 T11937 T11938 compound transcription,factors
R7829 T12019 T12018 punct .,enhanced
R7830 T12020 T12024 prep In,−
R7831 T11938 T11935 pobj factors,as
R7832 T12021 T12020 pobj addition,In
R7833 T12022 T12024 punct ",",−
R7834 T11939 T11928 prep in,array
R7835 T12023 T12024 nsubj CCR5,−
R7836 T12024 T12024 ROOT −,−
R7837 T12025 T12026 nummod /,−
R7838 T12026 T12027 nsubj −,prevented
R7839 T12027 T12024 ccomp prevented,−
R7840 T11940 T11942 amod diverse,responses
R7841 T12028 T12029 det the,phosphorylation
R7842 T12029 T12027 dobj phosphorylation,prevented
R7843 T12030 T12029 prep of,phosphorylation
R7844 T11941 T11942 amod immune,responses
R7845 T12031 T12030 pobj IκB,of
R7846 T12032 T12029 punct ",",phosphorylation
R7847 T12033 T12027 advcl accompanied,prevented
R7848 T11942 T11939 pobj responses,in
R7849 T12034 T12033 prep with,accompanied
R7850 T12035 T12036 det the,inhibition
R7851 T12036 T12034 pobj inhibition,with
R7852 T11943 T11947 punct ",",recognized
R7853 T12037 T12036 prep of,inhibition
R7854 T12038 T12039 det the,p50
R7855 T11944 T11947 nsubjpass NF-κB,recognized
R7856 T12039 T12037 pobj p50,of
R7857 T12040 T12039 cc and,p50
R7858 T12041 T12042 nummod p65,translocation
R7859 T11945 T11947 aux has,recognized
R7860 T12042 T12039 conj translocation,p50
R7861 T12043 T12033 prep into,accompanied
R7862 T12044 T12045 det the,nucleus
R7863 T11946 T11947 auxpass been,recognized
R7864 T12045 T12043 pobj nucleus,into
R7865 T12046 T12048 punct (,2A-C
R7866 T12047 T12048 compound Figure,2A-C
R7867 T11947 T11947 ROOT recognized,recognized
R7868 T12048 T12045 appos 2A-C,nucleus
R7869 T12049 T12048 punct ),2A-C
R7870 T12050 T12024 punct .,−
R7871 T11948 T11947 prep as,recognized
R7872 T12051 T12052 amod Many,tumors
R7873 T12052 T12058 nsubj tumors,increased
R7874 T11949 T11951 det a,factor
R7875 T12053 T12052 punct ",",tumors
R7876 T12054 T12052 prep including,tumors
R7877 T12055 T12054 pobj melanoma,including
R7878 T12056 T12052 punct ",",tumors
R7879 T11950 T11951 amod major,factor
R7880 T12057 T12058 aux have,increased
R7881 T12058 T12058 ROOT increased,increased
R7882 T12059 T12058 dobj levels,increased
R7883 T11951 T11948 pobj factor,as
R7884 T12060 T12059 prep of,levels
R7885 T12061 T12062 compound NF-κB,[
R7886 T12062 T12060 pobj [,of
R7887 T12063 T12064 nummod 40,]
R7888 T12064 T12059 appos ],levels
R7889 T11952 T11951 amod responsible,factor
R7890 T12065 T12064 punct ",",]
R7891 T12066 T12067 nsubj which,is
R7892 T12067 T12064 relcl is,]
R7893 T11953 T11952 prep for,responsible
R7894 T12068 T12067 acomp likely,is
R7895 T12069 T12068 xcomp acting,likely
R7896 T12070 T12069 prep as,acting
R7897 T11954 T11956 amod cytokine-associated,development
R7898 T12071 T12073 det a,factor
R7899 T12072 T12073 compound survival,factor
R7900 T12073 T12070 pobj factor,as
R7901 T11955 T11956 compound cancer,development
R7902 T12074 T12073 prep for,factor
R7903 T12075 T12076 compound melanoma,growth
R7904 T12076 T12074 pobj growth,for
R7905 T11956 T11953 pobj development,for
R7906 T12077 T12058 punct .,increased
R7907 T12078 T12091 advmod Thus,are
R7908 T12079 T12091 punct ",",are
R7909 T11957 T11956 cc or,development
R7910 T12080 T12081 det the,inhibitions
R7911 T12081 T12091 nsubj inhibitions,are
R7912 T12082 T12081 prep of,inhibitions
R7913 T11958 T11959 amod anti-tumor,immunity
R7914 T12083 T12084 amod NF-κB,activity
R7915 T12084 T12082 pobj activity,of
R7916 T12085 T12084 cc and,activity
R7917 T11959 T11956 conj immunity,development
R7918 T12086 T12087 det the,expression
R7919 T12087 T12084 conj expression,activity
R7920 T11960 T11947 punct .,recognized
R7921 T12088 T12087 prep of,expression
R7922 T12089 T12090 compound target,genes
R7923 T12090 T12088 pobj genes,of
R7924 T11961 T11970 prep In,/
R7925 T12091 T12091 ROOT are,are
R7926 T12092 T12091 acomp critical,are
R7927 T11962 T11965 det the,tissues
R7928 T11963 T11965 compound melanoma,tissues
R7929 T12093 T12092 prep in,critical
R7930 T11964 T11965 compound tumor,tissues
R7931 T12094 T12095 det the,inhibition
R7932 T12095 T12093 pobj inhibition,in
R7933 T12096 T12095 prep of,inhibition
R7934 T11965 T11961 pobj tissues,In
R7935 T12097 T12098 compound tumor,growth
R7936 T12098 T12096 pobj growth,of
R7937 T12099 T12091 prep in,are
R7938 T12100 T12104 nummod CCR5,mice
R7939 T11966 T11965 prep of,tissues
R7940 T12101 T12104 nummod −,mice
R7941 T12102 T12104 nmod /,mice
R7942 T12103 T12104 compound −,mice
R7943 T12104 T12099 pobj mice,in
R7944 T11967 T11969 det the,−
R7945 T12105 T12091 punct .,are
R7946 T12106 T12109 mark Although,is
R7947 T12107 T12108 det the,mechanism
R7948 T11968 T11969 compound CCR5,−
R7949 T12108 T12109 nsubj mechanism,is
R7950 T12109 T12123 advcl is,is
R7951 T12110 T12111 neg not,clear
R7952 T11969 T11966 pobj −,of
R7953 T12111 T12109 acomp clear,is
R7954 T12112 T12123 prep as,is
R7955 T12113 T12112 pcomp to,as
R7956 T11970 T11999 advcl /,inhibited
R7957 T12114 T12116 advmod how,−
R7958 T11971 T11972 nummod −,mice
R7959 T11972 T11970 dobj mice,/
R7960 T11973 T11999 punct ",",inhibited
R7961 T12115 T12116 nsubj CCR5,−
R7962 T11974 T11975 det the,expression
R7963 T12116 T12123 advcl −,is
R7964 T12117 T12119 nummod /,downregulates
R7965 T11975 T11999 nsubjpass expression,inhibited
R7966 T11976 T11975 prep of,expression
R7967 T11977 T11981 amod NF-κB,genes
R7968 T12118 T12119 compound −,downregulates
R7969 T11978 T11979 compound target,cell
R7970 T12119 T12120 compound downregulates,NF-κB
R7971 T12120 T12116 dobj NF-κB,−
R7972 T12121 T12123 punct ",",is
R7973 T11979 T11980 compound cell,death
R7974 T12122 T12123 nsubj it,is
R7975 T12123 T12123 ROOT is,is
R7976 T12124 T12123 acomp noteworthy,is
R7977 T11980 T11981 compound death,genes
R7978 T12125 T12128 mark that,activated
R7979 T12126 T12128 nsubjpass NF-κB,activated
R7980 T11981 T11976 pobj genes,of
R7981 T12127 T12128 auxpass is,activated
R7982 T12128 T12123 ccomp activated,is
R7983 T12129 T12128 cc or,activated
R7984 T11982 T11999 punct (,inhibited
R7985 T12130 T12128 conj inactivated,activated
R7986 T12131 T12130 agent by,inactivated
R7987 T12132 T12133 amod many,cytokines
R7988 T12133 T12131 pobj cytokines,by
R7989 T12134 T12123 punct .,is
R7991 T11983 T11999 nsubjpass Bax,inhibited
R7994 T11984 T11983 punct ",",Bax
R7998 T11985 T11983 conj caspase-3,Bax
R8002 T11986 T11985 cc and,caspase-3
R8005 T11987 T11985 conj 9,caspase-3
R8009 T11988 T11987 punct ),9
R8012 T11989 T11985 cc and,caspase-3
R8016 T11990 T11993 det the,activity
R8020 T11991 T11993 compound DNA,activity
R8024 T11992 T11993 amod binding,activity
R8028 T11993 T11985 conj activity,caspase-3
R8031 T11994 T11993 prep of,activity
R8035 T11995 T11994 pobj NF-κB,of
R8039 T11996 T11997 punct ",",were
R8041 T11997 T11999 auxpass were,inhibited
R8045 T11998 T11999 advmod significantly,inhibited
R8049 T11999 T11999 ROOT inhibited,inhibited
R8052 T12000 T11999 punct ",",inhibited
R8056 T12001 T11999 cc but,inhibited
R8059 T12002 T12003 det the,expression
R8063 T12003 T12018 nsubjpass expression,enhanced
R8067 T12004 T12003 prep of,expression
R8071 T12005 T12006 compound cell,death
R8075 T12006 T12004 pobj death,of
R8079 T12007 T12010 amod inhibitory,genes
R8083 T12008 T12010 compound NF-κB,genes
R8086 T12009 T12010 compound target,genes
R8093 T12010 T12018 nsubjpass genes,enhanced
R8095 T12011 T12010 punct ",",genes
R8096 T12012 T12013 amod such,as
R8098 T12013 T12010 prep as,genes
R8100 T12014 T12013 pobj Bcl-2,as
R8106 T12015 T12014 cc and,Bcl-2
R8110 T12016 T12018 nsubjpass cIAP,enhanced
R8114 T12017 T12018 auxpass were,enhanced